X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16715) 16715
Book Review (3022) 3022
Publication (1563) 1563
Newspaper Article (290) 290
Book Chapter (133) 133
Conference Proceeding (70) 70
Book / eBook (69) 69
Web Resource (60) 60
Magazine Article (59) 59
Dissertation (30) 30
Government Document (28) 28
Streaming Video (11) 11
Trade Publication Article (11) 11
Data Set (5) 5
Paper (2) 2
Journal / eJournal (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12582) 12582
humans (11433) 11433
tuberculosis (7718) 7718
infectious diseases (4632) 4632
male (4205) 4205
female (4191) 4191
mycobacterium tuberculosis - drug effects (3686) 3686
adult (3628) 3628
antitubercular agents - therapeutic use (3595) 3595
tuberculosis, multidrug-resistant - drug therapy (3557) 3557
drug resistance (3544) 3544
microbiology (3072) 3072
middle aged (2751) 2751
mycobacterium-tuberculosis (2748) 2748
tuberculosis, multidrug-resistant - epidemiology (2585) 2585
respiratory system (2411) 2411
mycobacterium tuberculosis (2405) 2405
antitubercular agents - pharmacology (2402) 2402
multidrug-resistant tuberculosis (2395) 2395
microbial sensitivity tests (2228) 2228
mycobacterium tuberculosis - genetics (2004) 2004
tuberculosis, multidrug-resistant - microbiology (1987) 1987
mycobacterium tuberculosis - isolation & purification (1981) 1981
pulmonary tuberculosis (1842) 1842
adolescent (1725) 1725
drug resistance in microorganisms (1693) 1693
epidemiology (1670) 1670
pharmacology & pharmacy (1616) 1616
risk factors (1581) 1581
aged (1560) 1560
tuberculosis, pulmonary - drug therapy (1550) 1550
tuberculosis, multidrug-resistant - diagnosis (1471) 1471
immunology (1467) 1467
research (1403) 1403
treatment outcome (1384) 1384
animals (1336) 1336
drug therapy (1315) 1315
prevalence (1304) 1304
tuberculosis - drug therapy (1296) 1296
diagnosis (1293) 1293
analysis (1274) 1274
medicine, general & internal (1271) 1271
young adult (1218) 1218
child (1208) 1208
drug-resistant tuberculosis (1187) 1187
antitubercular agents (1159) 1159
infections (1149) 1149
public health (1139) 1139
tuberculosis - epidemiology (1139) 1139
health aspects (1124) 1124
abridged index medicus (1083) 1083
retrospective studies (1068) 1068
medicine (1053) 1053
mutation (1038) 1038
research article (1037) 1037
rifampin (1024) 1024
bacteria (1001) 1001
multidrug-resistant (996) 996
hiv (987) 987
drug resistance, multiple, bacterial (986) 986
infection (986) 986
care and treatment (965) 965
tuberculosis, pulmonary - epidemiology (941) 941
antibiotics (936) 936
multidrug resistant organisms (934) 934
drug resistance, bacterial (899) 899
tuberculosis, pulmonary - microbiology (888) 888
patients (870) 870
drugs (842) 842
antitubercular agents - administration & dosage (818) 818
resistant tuberculosis (815) 815
genotype (811) 811
resistant staphylococcus-aureus (797) 797
multidisciplinary sciences (794) 794
sputum - microbiology (790) 790
public, environmental & occupational health (781) 781
drug-resistance (775) 775
transmission (775) 775
strains (756) 756
anti-bacterial agents - pharmacology (748) 748
child, preschool (748) 748
mortality (748) 748
incidence (741) 741
rifampin - pharmacology (730) 730
tuberculosis - microbiology (722) 722
mdr-tb (717) 717
drug therapy, combination (713) 713
tuberculosis, multidrug-resistant - prevention & control (707) 707
infectious disease (690) 690
tuberculosis, pulmonary - diagnosis (676) 676
chemistry, medicinal (655) 655
tuberculosis - diagnosis (638) 638
isoniazid (629) 629
aids/hiv (621) 621
isoniazid - pharmacology (616) 616
drug resistance, microbial (611) 611
science (606) 606
global health (604) 604
infant (599) 599
hospitals (593) 593
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (41) 41
Gerstein Science - Stacks (38) 38
West Park Healthcare Centre - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Engineering & Comp. Sci. - Stacks (4) 4
UofT at Mississauga - Stacks (4) 4
Robarts - Government Pubs (3) 3
Scarborough Hospital - Online (3) 3
UofT at Scarborough - Stacks (3) 3
St. Michael's Hospital - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Media Commons - Microtexts (1) 1
New College (Ivey) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15570) 15570
French (508) 508
Spanish (314) 314
Russian (207) 207
Japanese (174) 174
Chinese (132) 132
German (124) 124
Portuguese (99) 99
Korean (87) 87
Italian (30) 30
Turkish (28) 28
Polish (27) 27
Romanian (24) 24
Czech (18) 18
Dutch (14) 14
Swedish (14) 14
Ukrainian (13) 13
Danish (10) 10
Norwegian (8) 8
Hungarian (6) 6
Croatian (5) 5
Bosnian (4) 4
Finnish (4) 4
Lithuanian (4) 4
Serbian (4) 4
Slovak (3) 3
Persian (2) 2
Arabic (1) 1
Catalan (1) 1
Icelandic (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


LANCET, ISSN 0140-6736, 03/2016, Volume 387, Issue 10024, pp. 1211 - 1226
Although the worldwide incidence of tuberculosis has been slowly decreasing, the global disease burden remains substantial (similar to 9 million cases and... 
MYCOBACTERIUM-TUBERCULOSIS | XPERT MTB/RIF ASSAY | DOSE-RANGING TRIAL | MEDICINE, GENERAL & INTERNAL | HEALTH-CARE WORKERS | RECONSTITUTION INFLAMMATORY SYNDROME | EXTENSIVELY DRUG-RESISTANT | PULMONARY TUBERCULOSIS | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | GAMMA RELEASE ASSAYS
Journal Article
LANCET, ISSN 0140-6736, 07/2011, Volume 378, Issue 9785, pp. 57 - 72
Tuberculosis results in an estimated 1.7 million deaths each year and the worldwide number of new cases (more than 9 million) is higher than at any other time... 
MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, GENERAL & INTERNAL | RESOURCE-LIMITED SETTINGS | RECONSTITUTION INFLAMMATORY SYNDROME | SUB-SAHARAN AFRICA | MULTIDRUG-RESISTANT TUBERCULOSIS | HIV-ASSOCIATED TUBERCULOSIS | ACID AMPLIFICATION TESTS | PULMONARY TUBERCULOSIS | ANTIRETROVIRAL THERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS
Journal Article
LANCET, ISSN 0140-6736, 12/2007, Volume 370, Issue 9604, pp. 2030 - 2043
Tuberculosis is still a leading cause of death in low-income and middle-income countries, especially those of sub-Saharan Africa where tuberculosis is an... 
INTERFERON-GAMMA-RECEPTOR | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | RECONSTITUTION INFLAMMATORY SYNDROME | MANNOSE-BINDING LECTIN | RESISTANT PULMONARY TUBERCULOSIS | BACILLE CALMETTE-GUERIN | ACTIVE ANTIRETROVIRAL THERAPY | ACID AMPLIFICATION TESTS | MYCOBACTERIUM-BOVIS BCG | HIV-INFECTED PATIENTS
Journal Article
by Furin, J and Cox, H and Pai, M
LANCET, ISSN 0140-6736, 04/2019, Volume 393, Issue 10181, pp. 1642 - 1656
Tuberculosis remains the leading cause of death from an infectious disease among adults worldwide, with more than 10 million people becoming newly sick from... 
MYCOBACTERIUM-TUBERCULOSIS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | MULTIDRUG-RESISTANT | COST-EFFECTIVENESS | LATENT TUBERCULOSIS | PULMONARY TUBERCULOSIS | MDR-TB | XDR-TB | XPERT MTB/RIF | DRUG-RESISTANT TUBERCULOSIS
Journal Article
NATURE REVIEWS DISEASE PRIMERS, ISSN 2056-676X, 10/2016, Volume 2
Tuberculosis (TB) is an airborne infectious disease caused by organisms of the Mycobacterium tuberculosis complex. Although primarily a pulmonary pathogen, M.... 
MIDDLE-INCOME COUNTRIES | XPERT MTB/RIF ASSAY | MEDICINE, GENERAL & INTERNAL | SUB-SAHARAN AFRICA | PLACEBO-CONTROLLED TRIAL | DIAGNOSED PULMONARY TUBERCULOSIS | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV-INFECTED ADULTS | DRUG-RESISTANT TUBERCULOSIS | GAMMA RELEASE ASSAYS | CLUSTER-RANDOMIZED TRIAL
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 01/2017, Volume 187, Issue 1, pp. 160 - 173
Journal Article
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 09/2014, Volume 18, Issue 9, pp. 1019 - 1025
BACKGROUND: Effective treatment for drug-susceptible tuberculosis (TB) rapidly renders patients noninfectious, long before conversion of sputum acid-fast smear... 
Impact of treatment | Multidrug-resistant tuberculosis | Extensively drug-resistant tuberculosis | Transmission | MYCOBACTERIUM-TUBERCULOSIS | TUBERCLE-BACILLI | SOUTH-AFRICA | INFECTIOUS DISEASES | multidrug-resistant tuberculosis | SETTINGS | CHEMOTHERAPY | VARIABILITY | transmission | impact of treatment | WARD | RESPIRATORY SYSTEM | extensively drug-resistant tuberculosis | PULMONARY TUBERCULOSIS | INFECTION | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Air Microbiology | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Infection Control - methods | Mycobacterium tuberculosis - drug effects | Tuberculin Test | Tuberculosis, Multidrug-Resistant - diagnosis | Cross Infection - transmission | Microbial Sensitivity Tests | Young Adult | Time Factors | Tuberculosis, Multidrug-Resistant - microbiology | Tuberculosis, Multidrug-Resistant - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Retrospective Studies | Antitubercular Agents - therapeutic use | Extensively Drug-Resistant Tuberculosis - drug therapy | Guinea Pigs | Cross Infection - prevention & control | Treatment Outcome | Mycobacterium tuberculosis - isolation & purification | Animals | Extensively Drug-Resistant Tuberculosis - transmission | Tuberculosis, Pulmonary - diagnosis | Cross Infection - microbiology | Adolescent | Cross Infection - diagnosis | Aged | Tuberculosis, Pulmonary - transmission | Tuberculosis, Multidrug-Resistant - drug therapy | Index Medicus | multidrug resistant tuberculosis | extensively drug resistant tuberculosis
Journal Article
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, ISSN 0012-0472, 10/2015, Volume 140, Issue 20, pp. 1508 - 1512
Zusammenfassung Die Tuberkulose gehort zu den bedeutendsten Ursachen fur Morbiditat und Mortalitat weltweit. Die zunehmende Entwicklung multiresistenter Stamme... 
personliche Medizin | ASSAY | Gesamt-Genomsequenzierung | whole-genome sequencing | MDR-TB | update | REGIMEN | XPERT MTB/RIF | RIFAPENTINE | IGRA | personalized medicine | EUROPE | MEDICINE, GENERAL & INTERNAL | MULTIDRUG-RESISTANT TUBERCULOSIS | MOXIFLOXACIN | RISK-ASSESSMENT
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2013, Volume 207, Issue 1, pp. 9 - 17
Background. Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this... 
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | tuberculosis | genotyping | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CARE | transmission | NEW-YORK-CITY | INFECTED PATIENTS | drug resistance | XDR-TB | OUTBREAK | SPREAD | STRAIN | EPIDEMIOLOGY | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2015, Volume 61, Issue suppl 3, pp. S102 - S118
Despite concerted efforts over the past 2 decades at developing new diagnostics, drugs, and vaccines with expanding pipelines, tuberculosis remains a global... 
diagnostics | Tuberculosis | drugs | management | vaccines | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | INTENSIVE PHASE TREATMENT | SUB-SAHARAN AFRICA | tuberculosis | AFRICAN POUCHED RATS | MICROBIOLOGY | IMMUNOLOGY | CROSS-PRIMING AMPLIFICATION | IN-VITRO | BACTERICIDAL ACTIVITY | MULTIDRUG-RESISTANT TUBERCULOSIS | PULMONARY TUBERCULOSIS | STANDARDIZED TREATMENT | Extensively Drug-Resistant Tuberculosis - drug therapy | Antitubercular Agents - chemistry | Point-of-Care Systems - economics | World Health Organization | Tuberculosis Vaccines | Extensively Drug-Resistant Tuberculosis - prevention & control | Humans | Tuberculosis - complications | Clinical Trials as Topic | Mycobacterium tuberculosis - drug effects | Tuberculosis - diagnosis | Tuberculosis, Multidrug-Resistant - diagnosis | Antitubercular Agents - classification | Tuberculosis, Multidrug-Resistant - prevention & control | Tuberculosis - drug therapy | Tuberculosis - prevention & control | HIV Infections - complications | Extensively Drug-Resistant Tuberculosis - diagnosis | Antitubercular Agents - therapeutic use | Mycobacterium tuberculosis - genetics | Tuberculosis, Multidrug-Resistant - drug therapy | Infectious diseases | Medical diagnosis | Drug therapy | Drug resistance | Index Medicus | A Blueprint for Opportunities | Advances in Tuberculosis Research
Journal Article
Book
JNP-JOURNAL FOR NURSE PRACTITIONERS, ISSN 1555-4155, 01/2015, Volume 11, Issue 1, pp. 87 - 94
Tuberculosis (TB) resulted in 1.3 million deaths and 8.6 million new cases of active TB worldwide in 2012. Clinical manifestations of TB include fever, night... 
acid-fast bacilli | latent TB | MULTIDRUG-RESISTANT | isoniazid | NURSING | pyrazinamide | tuberculosis | multidrug-resistant TB | tuberculin skin test | DRUG-RESISTANT TUBERCULOSIS | rifampin | ethambutol | interferon-gamma-release assay | INFECTION
Journal Article
Lancet (London, England), 03/2016, Volume 387, Issue 10024, p. 1211
Journal Article
Journal for Nurse Practitioners, ISSN 1555-4155, 2015, Volume 11, Issue 1, pp. 87 - 94
Tuberculosis (TB) resulted in 1.3 million deaths and 8.6 million new cases of active TB worldwide in 2012. Clinical manifestations of TB include fever, night... 
Latent TB | Multidrug-resistant TB | Tuberculosis | Acid-fast bacilli | Tuberculin skin test | Interferon-γ-release assay | Ethambutol | Pyrazinamide | Isoniazid | Rifampin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.